Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.13 trillion and total revenue of $109.89 billion.
Market Cap
1.13T
Revenue
109.89B
Profits
-41.32B
PE Ratio
n/a
Profit Margin
-37.60%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.33B | 1.24% | 1,482,949 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.57B | 0.46% | 815,879 | 14.92B |
| 3 | ARGX | argenx SE | 54.92B | -1.04% | 423,156 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.42B | 1.75% | 1,118,586 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 34.03B | 4.02% | 2,131,790 | - |
| 6 | RPRX | Royalty Pharma plc | 31.25B | -1.09% | 1,948,760 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 29.82B | 1.41% | 351,440 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.96B | 0.29% | 825,404 | 3.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 21.60B | -0.03% | 3,993,067 | 8.26M |
| 10 | INSM | Insmed Incorporated | 21.12B | -0.40% | 3,788,822 | 819.56M |
| 11 | MRNA | Moderna, Inc. | 20.68B | 4.45% | 6,342,068 | 2.23B |
| 12 | INCY | Incyte Corporation | 20.37B | -6.04% | 2,815,110 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.19B | -1.99% | 1,023,148 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | 0.01% | 690,988 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.87B | 2.40% | 638,053 | 998.25M |
| 16 | EXEL | Exelixis, Inc. | 13.32B | -0.24% | 2,025,466 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 1.80% | 3,087,110 | 579.96M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 13.04B | -0.69% | 628,430 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.22B | 0.93% | 1,506,352 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.52B | 3.95% | 284,647 | 1.13B |
| 21 | SMMT | Summit Therapeutics Inc. | 10.97B | 0.86% | 8,529,365 | - |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.87B | 3.53% | 1,115,910 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.76B | -0.54% | 1,458,251 | 3.24B |
| 24 | NUVL | Nuvalent, Inc. | 9.74B | 0.08% | 2,969,479 | - |
| 25 | CYTK | Cytokinetics, Incorporated | 9.69B | 1.75% | 1,012,619 | 105.82M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.57B | 2.13% | 263,548 | 417.30M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.92B | 0.25% | 1,043,279 | 769.10M |
| 28 | TECH | Bio-Techne Corporation | 8.79B | 4.02% | 3,298,764 | 1.21B |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.45B | 2.56% | 1,815,764 | 1.51B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.87B | 1.77% | 2,123,978 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.47B | 0.42% | 8,140,230 | 140.98M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | -0.77% | 544,246 | 7.46M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 7.26B | 3.45% | 1,156,437 | - |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 7.23B | 2.44% | 536,301 | 74.06M |
| 35 | PCVX | Vaxcyte, Inc. | 7.16B | 4.42% | 1,739,392 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 7.13B | 1.58% | 2,580,827 | 700.35M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 7.04B | -0.72% | 485,139 | 51.48M |
| 38 | IMVT | Immunovant, Inc. | 6.87B | -0.54% | 1,220,319 | - |
| 39 | LEGN | Legend Biotech Corporation | 6.59B | -1.09% | 1,449,914 | 1.14B |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.46B | -2.42% | 709,328 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.37B | 2.17% | 3,590,711 | 827.11M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.16B | 1.66% | 832,595 | 569.61M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.10% | 1,612,483 | 15.00M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | 1.49% | 2,259,557 | 217.17M |
| 45 | BLTE | Belite Bio, Inc | 5.67B | 4.40% | 242,584 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.67B | 0.21% | 1,974,759 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.50B | 3.94% | 824,499 | - |
| 48 | CGON | CG Oncology, Inc. | 5.25B | -0.02% | 962,080 | 5.07M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.14B | 1.17% | 1,579,323 | 907.29M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.08B | -0.90% | 159,043 | 274.48M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.07B | 5.64% | 1,828,502 | 4.10M |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.07B | 0.58% | 1,168,392 | 7.50M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.00B | 3.38% | 2,105,947 | 536.20M |
| 54 | TNGX | Tango Therapeutics, Inc. | 4.76B | 6.33% | 3,225,385 | 56.99M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | 0.54% | 764,555 | 1.34M |
| 56 | ERAS | Erasca, Inc. | 4.49B | 2.70% | 2,916,649 | - |
| 57 | CELC | Celcuity Inc. | 4.30B | -0.35% | 1,142,411 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.15B | -1.47% | 1,002,321 | - |
| 59 | MANE | Veradermics, Incorporated | 4.02B | 0.21% | 305,147 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.03% | 2,817,696 | 596.96M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.79B | 1.09% | 933,732 | - |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.70B | 1.89% | 931,328 | 18.07M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | 0.83% | 1,209,892 | 1.10B |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 3.58B | 0.66% | 694,953 | 22.57M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.53B | 2.59% | 1,448,824 | - |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.44B | 3.06% | 1,178,088 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.33B | -0.21% | 297,130 | 803.79M |
| 68 | RLAY | Relay Therapeutics, Inc. | 3.26B | 1.01% | 1,879,842 | 10.68M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.20B | 4.92% | 1,792,609 | 415.62M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.18B | -8.25% | 1,280,672 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 3.10B | 7.20% | 2,904,506 | 164.01M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.10B | 2.97% | 1,643,997 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.06B | 0.33% | 711,915 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.04B | 1.60% | 1,218,655 | 236.00M |
| 75 | ALMS | Alumis Inc. | 2.93B | -4.76% | 1,557,725 | 8.40M |
| 76 | IRON | Disc Medicine, Inc. | 2.68B | 3.09% | 464,051 | - |
| 77 | TARS | Tarsus Pharmaceuticals, Inc. | 2.66B | -0.16% | 502,416 | 535.08M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.66B | 4.31% | 1,247,939 | 225.27M |
| 79 | DFTX | Definium Therapeutics, Inc. | 2.59B | -3.96% | 1,386,893 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.58B | -8.17% | 2,790,719 | - |
| 81 | KLRA | Kailera Therapeutics, Inc. | 2.55B | 4.13% | 404,045 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.52B | 2.72% | 1,007,165 | 865.00K |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | 4.23% | 1,479,243 | 670.00M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.06% | 560,107 | - |
| 85 | PHVS | Pharvaris N.V. | 2.20B | 2.67% | 122,964 | - |
| 86 | KOD | Kodiak Sciences Inc. | 2.13B | - | 513,677 | - |
| 87 | NTLA | Intellia Therapeutics, Inc. | 2.08B | 23.20% | 16,409,534 | 66.09M |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.08B | 3.17% | 1,351,102 | - |
| 89 | NKTR | Nektar Therapeutics | 2.07B | 2.97% | 674,247 | 55.63M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.14% | 1,122,737 | 298.30M |
| 91 | IMNM | Immunome, Inc. | 2.05B | -1.69% | 905,151 | 4.02M |
| 92 | ZLAB | Zai Lab Limited | 1.99B | 3.87% | 637,972 | 453.28M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.81% | 985,838 | 899.11M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | 1.27% | 1,758,276 | - |
| 95 | ADMA | ADMA Biologics, Inc. | 1.97B | 3.53% | 4,513,133 | 509.86M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.97B | 0.56% | 2,467,341 | 52.04M |
| 97 | VCEL | Vericel Corporation | 1.96B | 2.22% | 476,553 | 292.09M |
| 98 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -0.83% | 383,468 | 1.20B |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 8.01% | 1,651,790 | 66.05M |
| 100 | NBTX | Nanobiotix S.A. | 1.87B | 4.45% | 118,955 | 38.27M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.87B | 0.60% | 833,893 | 32.08M |
| 102 | MBX | MBX Biosciences, Inc. | 1.86B | 9.77% | 1,259,810 | - |
| 103 | RAPP | Rapport Therapeutics, Inc. | 1.83B | -0.36% | 317,190 | 20.00M |
| 104 | BHVN | Biohaven Ltd. | 1.83B | 7.62% | 4,471,545 | - |
| 105 | VRDN | Viridian Therapeutics, Inc. | 1.80B | -0.31% | 1,707,697 | 70.92M |
| 106 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -1.23% | 12,659,269 | 285.61M |
| 107 | MESO | Mesoblast Limited | 1.79B | -1.22% | 123,959 | 65.38M |
| 108 | NUVB | Nuvation Bio Inc. | 1.79B | 4.47% | 4,183,911 | 143.05M |
| 109 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 0.53% | 2,683,970 | 71.78M |
| 110 | QURE | uniQure N.V. | 1.76B | 1.09% | 1,094,007 | 18.09M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | 4.44% | 15,393,577 | 66.41M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.74B | 9.69% | 619,378 | 30.30M |
| 113 | ANAB | AnaptysBio, Inc. | 1.73B | 6.14% | 668,557 | 232.39M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 4.55% | 5,629,772 | 7.47M |
| 115 | PGEN | Precigen, Inc. | 1.71B | 7.87% | 6,770,942 | 31.60M |
| 116 | ZYME | Zymeworks Inc. | 1.70B | 1.66% | 526,428 | 81.26M |
| 117 | TYRA | Tyra Biosciences, Inc. | 1.70B | 5.78% | 987,118 | - |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 7.08% | 265,185 | - |
| 119 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | 3.00% | 2,311,747 | 2.18B |
| 120 | INVA | Innoviva, Inc. | 1.65B | -1.41% | 709,836 | 420.69M |
| 121 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 1.26% | 1,953,136 | 217.17M |
| 122 | SION | Sionna Therapeutics, Inc. | 1.63B | 0.22% | 278,622 | - |
| 123 | SEPN | Septerna, Inc. | 1.62B | 0.22% | 287,821 | 72.26M |
| 124 | ABCL | AbCellera Biologics Inc. | 1.61B | 0.38% | 3,696,533 | 79.21M |
| 125 | FTRE | Fortrea Holdings Inc. | 1.57B | 0.91% | 948,703 | 2.71B |
| 126 | AAPG | Ascentage Pharma Group International | 1.55B | -1.48% | 11,560 | 82.08M |
| 127 | CAPR | Capricor Therapeutics, Inc. | 1.55B | 3.57% | 987,108 | 11.13M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -0.66% | 745,359 | 42.95M |
| 129 | NVAX | Novavax, Inc. | 1.51B | 3.72% | 3,573,034 | 596.34M |
| 130 | URGN | UroGen Pharma Ltd. | 1.50B | 3.85% | 804,921 | 140.49M |
| 131 | IMCR | Immunocore Holdings plc | 1.46B | -1.14% | 237,291 | 412.81M |
| 132 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,397,695 | 65.50M |
| 133 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | -1.28% | 5,860,879 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.42B | -0.60% | 375,450 | - |
| 135 | ATAI | AtaiBeckley Inc. | 1.41B | -2.04% | 3,351,466 | 3.49M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.41B | 2.68% | 576,553 | - |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -0.79% | 352,607 | - |
| 138 | ARDX | Ardelyx, Inc. | 1.40B | -0.09% | 3,105,302 | 427.68M |
| 139 | GHRS | GH Research PLC | 1.40B | -3.55% | 159,502 | - |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 1.42% | 389,137 | 1.30M |
| 141 | SVRA | Savara Inc. | 1.35B | 1.33% | 1,287,870 | - |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.91% | 635,368 | 20.00M |
| 143 | IMTX | Immatics N.V. | 1.29B | 0.53% | 163,454 | 43.00M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.28B | -0.40% | 2,916,016 | 204.73M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.27B | 0.76% | 204,992 | - |
| 146 | MNKD | MannKind Corporation | 1.24B | 9.29% | 5,605,231 | 360.78M |
| 147 | DMRA | Damora Therapeutics, Inc. | 1.24B | -3.42% | 628,956 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.20B | -4.42% | 275,600 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -5.51% | 511,910 | 10.00M |
| 150 | WVE | Wave Life Sciences Ltd. | 1.15B | 2.21% | 2,357,591 | 71.80M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.14B | -5.65% | 488,907 | 8.28M |
| 152 | ABSI | Absci Corporation | 1.13B | 6.91% | 6,727,791 | 1.84M |
| 153 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | 0.40% | 199,711 | - |
| 154 | DBVT | DBV Technologies S.A. | 1.09B | 4.02% | 176,082 | 5.74M |
| 155 | EYPT | EyePoint, Inc. | 1.01B | -7.29% | 1,084,003 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.25% | 707,995 | - |
| 157 | SPRY | ARS Pharmaceuticals, Inc. | 974.17M | 0.51% | 1,049,911 | 98.99M |
| 158 | JBIO | Jade Biosciences, Inc. | 955.69M | 4.95% | 1,295,791 | - |
| 159 | SPTX | Seaport Therapeutics, Inc. | 924.81M | -3.11% | 104,012 | - |
| 160 | PHAR | Pharming Group N.V. | 909.55M | 0.04% | 3,583 | 369.49M |
| 161 | XNCR | Xencor, Inc. | 905.27M | -0.97% | 638,904 | 97.36M |
| 162 | MGTX | MeiraGTx Holdings plc | 902.94M | 1.67% | 634,638 | 79.76M |
| 163 | DRTS | Alpha Tau Medical Ltd. | 872.00M | -1.83% | 668,580 | - |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 870.62M | 2.08% | 2,081,608 | 69.64M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 869.55M | 1.57% | 1,241,464 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 862.99M | 0.10% | 1,322,099 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 854.71M | 6.34% | 2,786,004 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 853.36M | 1.41% | 1,097,053 | 191.45M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 850.70M | 3.28% | 692,090 | 204.89M |
| 170 | KURA | Kura Oncology, Inc. | 846.91M | 5.41% | 1,680,637 | 71.64M |
| 171 | TBPH | Theravance Biopharma, Inc. | 841.35M | -1.92% | 346,349 | 109.78M |
| 172 | JANX | Janux Therapeutics, Inc. | 837.93M | 1.33% | 574,656 | 13.73M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 836.44M | -0.66% | 1,790,104 | - |
| 174 | ODTX | Odyssey Therapeutics, Inc. | 832.62M | 4.44% | 278,315 | 2.98M |
| 175 | LBRX | LB Pharmaceuticals Inc | 817.28M | 0.28% | 201,998 | - |
| 176 | IVA | Inventiva S.A. | 788.03M | -2.34% | 350,666 | 7.94M |
| 177 | AVTX | Avalo Therapeutics, Inc. | 767.46M | -1.08% | 950,291 | 59.00K |
| 178 | VOR | Vor Biopharma Inc. | 762.40M | -2.02% | 1,913,103 | - |
| 179 | ANNX | Annexon, Inc. | 760.23M | -1.49% | 2,898,248 | - |
| 180 | EVMN | Evommune, Inc. | 750.62M | 5.09% | 447,758 | 10.00M |
| 181 | ANRO | Alto Neuroscience, Inc. | 742.94M | -1.40% | 246,761 | - |
| 182 | ZVRA | Zevra Therapeutics, Inc. | 741.89M | -0.79% | 1,873,006 | 122.29M |
| 183 | REPL | Replimune Group, Inc. | 739.85M | 0.90% | 1,980,789 | - |
| 184 | GERN | Geron Corporation | 737.75M | - | 9,845,351 | 196.12M |
| 185 | SLDB | Solid Biosciences Inc. | 724.59M | 3.08% | 2,064,045 | - |
| 186 | AURA | Aura Biosciences, Inc. | 711.43M | 0.62% | 581,906 | - |
| 187 | OCS | Oculis Holding AG | 701.11M | 4.69% | 760,046 | 1.40M |
| 188 | DSGN | Design Therapeutics, Inc. | 695.77M | 1.55% | 823,822 | - |
| 189 | TENX | Tenax Therapeutics, Inc. | 680.04M | 0.61% | 760,046 | - |
| 190 | OMER | Omeros Corporation | 675.26M | 6.75% | 1,960,054 | 9.89M |
| 191 | CRMD | CorMedix Inc. | 673.90M | -1.72% | 1,412,783 | 400.05M |
| 192 | ALLO | Allogene Therapeutics, Inc. | 669.60M | 2.11% | 5,800,151 | 22.00K |
| 193 | RLMD | Relmada Therapeutics, Inc. | 668.15M | -4.21% | 3,076,360 | - |
| 194 | CTMX | CytomX Therapeutics, Inc. | 661.82M | 1.00% | 2,921,561 | 35.54M |
| 195 | SGP | SpyGlass Pharma, Inc. | 633.10M | 2.71% | 143,816 | - |
| 196 | CADL | Candel Therapeutics, Inc. | 627.19M | - | 1,628,266 | - |
| 197 | TRAX | First Tracks Biotherapeutics, Inc. | 623.88M | 1.36% | 484,307 | - |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 619.23M | -0.26% | 344,678 | - |
| 199 | RIGL | Rigel Pharmaceuticals, Inc. | 618.34M | 1.74% | 278,440 | 299.77M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | 0.93% | 1,675,624 | 8.37M |
| 201 | CBIO | Crescent Biopharma, Inc. | 604.44M | 1.51% | 179,387 | 11.88M |
| 202 | DRUG | Bright Minds Biosciences Inc. | 592.93M | -2.92% | 938,947 | - |
| 203 | IMMX | Immix Biopharma, Inc. | 591.13M | 0.24% | 970,602 | - |
| 204 | ACHV | Achieve Life Sciences, Inc. | 574.89M | 1.45% | 1,944,947 | - |
| 205 | TECX | Tectonic Therapeutic, Inc. | 554.57M | -2.94% | 103,599 | - |
| 206 | CLYM | Climb Bio, Inc. | 548.86M | 0.44% | 1,177,950 | - |
| 207 | MDXG | MiMedx Group, Inc. | 548.12M | 2.22% | 1,077,225 | 389.42M |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 537.62M | 4.31% | 651,929 | 151.40M |
| 209 | VRXA | VERAXA Biotech AG | 536.12M | 6.30% | 59,878 | - |
| 210 | GYRE | Gyre Therapeutics, Inc. | 535.44M | -1.18% | 57,132 | 117.05M |
| 211 | XOMA | XOMA Royalty Corporation | 526.10M | 0.38% | 108,427 | 48.56M |
| 212 | PRME | Prime Medicine, Inc. | 523.79M | 4.50% | 2,913,521 | 4.03M |
| 213 | ALT | Altimmune, Inc. | 513.41M | 1.15% | 3,516,864 | 36.00K |
| 214 | EIKN | Eikon Therapeutics, Inc. | 505.11M | 6.63% | 316,028 | - |
| 215 | PROK | ProKidney Corp. | 504.44M | 1.83% | 570,287 | 889.00K |
| 216 | VALN | Valneva SE | 504.32M | 0.56% | 14,958 | 180.25M |
| 217 | STRO | Sutro Biopharma, Inc. | 500.43M | 4.86% | 188,659 | 99.61M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 493.32M | 1.12% | 580,973 | - |
| 219 | AGMB | AgomAb Therapeutics NV | 492.48M | 4.06% | 158,924 | - |
| 220 | CABA | Cabaletta Bio, Inc. | 490.79M | - | 3,241,702 | - |
| 221 | ARVN | Arvinas, Inc. | 483.26M | -1.19% | 575,600 | 89.40M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 481.99M | 4.42% | 1,064,934 | 88.24M |
| 223 | CTNM | Contineum Therapeutics, Inc. | 475.55M | 7.07% | 430,244 | - |
| 224 | NGNE | Neurogene Inc. | 471.84M | 2.61% | 116,270 | 925.00K |
| 225 | ASMB | Assembly Biosciences, Inc. | 462.53M | 1.66% | 173,207 | 71.10M |
| 226 | ANL | Adlai Nortye Ltd. | 453.20M | 9.79% | 144,366 | 5.00M |
| 227 | RZLT | Rezolute, Inc. | 452.34M | 8.25% | 2,398,386 | - |
| 228 | ARTV | Artiva Biotherapeutics, Inc. | 446.04M | 7.49% | 782,333 | 251.00K |
| 229 | PRLD | Prelude Therapeutics Incorporated | 442.33M | -0.67% | 327,389 | 16.72M |
| 230 | FBRX | Forte Biosciences, Inc. | 441.06M | 2.79% | 124,994 | - |
| 231 | PRTA | Prothena Corporation plc | 426.68M | -1.21% | 622,612 | 57.94M |
| 232 | CCCC | C4 Therapeutics, Inc. | 422.37M | -2.05% | 1,558,174 | 34.86M |
| 233 | OVID | Ovid Therapeutics Inc. | 421.81M | -1.74% | 1,843,325 | 7.12M |
| 234 | INDP | Indaptus Therapeutics, Inc. | 417.86M | 3.07% | 378,879 | - |
| 235 | VTVT | vTv Therapeutics Inc. | 416.22M | 2.35% | 52,212 | 36.84M |
| 236 | IPSC | Century Therapeutics, Inc. | 414.82M | 2.22% | 1,081,684 | 109.16M |
| 237 | OCGN | Ocugen, Inc. | 413.00M | 0.83% | 6,340,386 | 4.47M |
| 238 | MNPR | Monopar Therapeutics Inc. | 411.77M | 2.84% | 154,193 | - |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 407.52M | 2.98% | 256,275 | - |
| 240 | SGMT | Sagimet Biosciences Inc. | 399.53M | -0.15% | 605,514 | - |
| 241 | AUTL | Autolus Therapeutics plc | 399.21M | -3.85% | 1,277,603 | 92.62M |
| 242 | BNTC | Benitec Biopharma Inc. | 389.23M | 1.34% | 83,049 | - |
| 243 | XFOR | X4 Pharmaceuticals, Inc. | 384.82M | 2.00% | 511,669 | 9.01M |
| 244 | EDIT | Editas Medicine, Inc. | 377.52M | -1.60% | 2,466,345 | 38.69M |
| 245 | LRMR | Larimar Therapeutics, Inc. | 374.73M | 3.46% | 1,670,476 | - |
| 246 | CMPX | Compass Therapeutics, Inc. | 367.38M | 0.49% | 2,174,768 | 850.00K |
| 247 | RGNX | REGENXBIO Inc. | 365.50M | 6.16% | 1,642,813 | 87.82M |
| 248 | LXEO | Lexeo Therapeutics, Inc. | 365.13M | 6.41% | 2,464,304 | - |
| 249 | PBYI | Puma Biotechnology, Inc. | 359.86M | -3.55% | 177,468 | 227.18M |
| 250 | STTK | Shattuck Labs, Inc. | 355.03M | -6.28% | 946,391 | 1.00M |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 353.60M | 0.17% | 1,131,182 | 217.78M |
| 252 | VSTM | Verastem, Inc. | 351.49M | -2.44% | 2,323,691 | 49.59M |
| 253 | ZURA | Zura Bio Limited | 349.16M | -0.54% | 517,306 | - |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 348.12M | -3.12% | 210,714 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 343.62M | -2.70% | 59,592 | - |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 332.66M | -3.87% | 114,012 | 69.21M |
| 257 | UPB | Upstream Bio, Inc. | 331.96M | - | 681,423 | 3.32M |
| 258 | SLN | Silence Therapeutics plc | 330.64M | 4.63% | 406,276 | 839.00K |
| 259 | ABEO | Abeona Therapeutics Inc. | 323.16M | 2.53% | 620,439 | 14.54M |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 319.23M | 2.11% | 124,377 | 51.00M |
| 261 | IRD | Opus Genetics, Inc. | 318.66M | -3.09% | 642,962 | 11.98M |
| 262 | LYEL | Lyell Immunopharma, Inc. | 316.18M | 0.37% | 82,710 | 31.00K |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 312.29M | 4.00% | 2,249,443 | - |
| 264 | LCTX | Lineage Cell Therapeutics, Inc. | 306.64M | -3.15% | 1,318,703 | 14.78M |
| 265 | OABI | OmniAb, Inc. | 305.89M | -7.05% | 468,960 | 28.94M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 303.36M | -0.35% | 185,767 | - |
| 267 | NVCT | Nuvectis Pharma, Inc. | 295.76M | 4.11% | 76,187 | - |
| 268 | BCYC | Bicycle Therapeutics plc | 289.72M | 2.47% | 2,982,353 | 63.50M |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 285.93M | 0.45% | 347,194 | - |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | - | 375,350 | 1.00 |
| 271 | PALI | Palisade Bio, Inc. | 282.95M | -1.17% | 2,109,869 | - |
| 272 | NAGE | Niagen Bioscience, Inc. | 280.94M | 2.03% | 556,688 | 130.42M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 274.08M | 17.12% | 5,977,056 | 114.70K |
| 274 | IMRX | Immuneering Corporation | 271.08M | - | 900,409 | - |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | 269.08M | 0.80% | 1,255,721 | 26.87M |
| 276 | SRZN | Surrozen, Inc. | 268.66M | -1.07% | 183,248 | 7.49M |
| 277 | ELDN | Eledon Pharmaceuticals, Inc. | 265.15M | -3.92% | 961,393 | - |
| 278 | MGNX | MacroGenics, Inc. | 262.52M | 4.29% | 620,482 | 157.08M |
| 279 | IVVD | Invivyd, Inc. | 255.90M | 12.81% | 13,276,191 | 55.87M |
| 280 | ARMP | Armata Pharmaceuticals, Inc. | 253.56M | -8.84% | 41,676 | 5.20M |
| 281 | RNAC | Cartesian Therapeutics, Inc. | 252.68M | -9.57% | 260,129 | 1.78M |
| 282 | CNXU | Conexeu Sciences Inc. | 248.15M | -13.02% | 91,566 | - |
| 283 | SLGL | Sol-Gel Technologies Ltd. | 241.32M | 0.52% | 33,851 | 18.47M |
| 284 | FHTX | Foghorn Therapeutics Inc. | 241.31M | -1.67% | 129,707 | 28.22M |
| 285 | ADAG | Adagene Inc. | 240.50M | 1.96% | 18,082 | 7.67M |
| 286 | IFRX | InflaRx N.V. | 238.61M | 1.25% | 974,853 | 33.82K |
| 287 | YDES | YD Bio Limited | 238.39M | 3.67% | 3,301 | 510.36K |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 237.73M | -3.17% | 157,087 | 32.72M |
| 289 | HUMA | Humacyte, Inc. | 237.56M | 1.42% | 5,692,745 | 2.02M |
| 290 | TRDA | Entrada Therapeutics, Inc. | 236.92M | 1.78% | 192,403 | 5.74M |
| 291 | FATE | Fate Therapeutics, Inc. | 234.28M | -2.43% | 2,859,148 | 6.32M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 233.88M | 1.74% | 3,334,972 | 80.00M |
| 293 | CLLS | Cellectis S.A. | 233.50M | 0.65% | 9,984 | 75.11M |
| 294 | ACIU | AC Immune SA | 232.13M | 1.30% | 145,141 | 4.62M |
| 295 | AVXL | Anavex Life Sciences Corp. | 231.68M | - | 934,374 | - |
| 296 | CDXS | Codexis, Inc. | 226.33M | 3.75% | 488,668 | 78.09M |
| 297 | CNTN | Canton Strategic Holdings, Inc. | 224.07M | 3.88% | 1,017,794 | - |
| 298 | TARA | Protara Therapeutics, Inc. | 221.44M | 1.03% | 494,767 | - |
| 299 | VYGR | Voyager Therapeutics, Inc. | 219.33M | 3.71% | 329,573 | 36.49M |
| 300 | RNA | Atrium Therapeutics, Inc. | 218.10M | 3.07% | 261,506 | 36.68M |
| 301 | QTTB | Q32 Bio Inc. | 218.06M | 1.74% | 361,241 | 53.74M |
| 302 | KPTI | Karyopharm Therapeutics Inc. | 217.39M | 1.47% | 172,463 | 151.12M |
| 303 | HELP | Cybin Inc. | 212.65M | -1.16% | 613,092 | - |
| 304 | ALXO | ALX Oncology Holdings Inc. | 212.60M | - | 1,638,392 | - |
| 305 | CHRS | Coherus Oncology, Inc. | 209.78M | -2.86% | 708,531 | 46.88M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 208.34M | 5.16% | 261,918 | 54.71M |
| 307 | LENZ | LENZ Therapeutics, Inc. | 207.88M | -2.07% | 466,811 | 20.99M |
| 308 | CAMP | Camp4 Therapeutics Corporation | 205.63M | -5.49% | 88,371 | 3.93M |
| 309 | NERV | Minerva Neurosciences, Inc. | 204.52M | -2.66% | 132,515 | - |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 202.76M | -1.44% | 253,668 | 7.15M |
| 311 | KROS | Keros Therapeutics, Inc. | 202.67M | 0.89% | 347,726 | 33.18M |
| 312 | NGEN | NervGen Pharma Corp. | 197.54M | -3.12% | 838,626 | - |
| 313 | NKTX | Nkarta, Inc. | 196.03M | -4.20% | 470,648 | - |
| 314 | TTRX | Turn Therapeutics Inc. | 191.24M | 6.12% | 70,528 | - |
| 315 | CGEN | Compugen Ltd. | 191.06M | -0.98% | 288,554 | 72.66M |
| 316 | IMUX | Immunic, Inc. | 190.84M | 1.08% | 139,079 | - |
| 317 | UNCY | Unicycive Therapeutics, Inc. | 190.10M | -1.79% | 1,038,381 | - |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.64M | 1.50% | 423,918 | 17.56M |
| 319 | MDWD | MediWound Ltd. | 179.29M | -1.90% | 64,155 | 14.48M |
| 320 | MIST | Milestone Pharmaceuticals Inc. | 178.23M | 3.15% | 1,929,591 | 1.78M |
| 321 | EQ | Equillium, Inc. | 177.03M | -0.36% | 362,455 | 4.39M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 176.74M | 3.59% | 218,339 | - |
| 323 | GALT | Galectin Therapeutics Inc. | 172.55M | -1.87% | 291,702 | - |
| 324 | NBP | NovaBridge Biosciences | 170.00M | -1.34% | 568,159 | - |
| 325 | OKUR | OnKure Therapeutics, Inc. | 169.66M | - | 164,126 | - |
| 326 | NMRA | Neumora Therapeutics, Inc. | 169.44M | -48.62% | 17,741,653 | - |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 169.01M | -1.27% | 280,697 | - |
| 328 | IPHA | Innate Pharma S.A. | 168.74M | 1.70% | 42,658 | 10.57M |
| 329 | SPRO | Spero Therapeutics, Inc. | 168.49M | 2.11% | 938,026 | 61.19M |
| 330 | KRRO | Korro Bio, Inc. | 168.17M | 0.43% | 244,838 | 3.84M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 165.98M | -1.44% | 578,488 | 76.38M |
| 332 | CRBU | Caribou Biosciences, Inc. | 164.64M | 4.08% | 1,707,645 | 11.20M |
| 333 | PRQR | ProQR Therapeutics N.V. | 164.37M | 8.33% | 719,739 | 15.73M |
| 334 | ALEC | Alector, Inc. | 164.32M | -3.27% | 629,573 | 18.42M |
| 335 | KZIA | Kazia Therapeutics Limited | 160.89M | -1.40% | 146,789 | 1.27M |
| 336 | DTIL | Precision BioSciences, Inc. | 160.23M | 1.80% | 144,271 | 45.07M |
| 337 | ENLV | Enlivex Ltd. | 159.12M | -1.49% | 306,141 | - |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 157.16M | -0.78% | 136,024 | 2.00M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 155.96M | 0.97% | 2,131,793 | 225.00K |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.15M | 1.59% | 335,487 | - |
| 341 | NRXP | NRx Pharmaceuticals, Inc. | 147.68M | 6.25% | 773,881 | 2.29M |
| 342 | HURA | TuHURA Biosciences, Inc. | 144.56M | -2.16% | 782,753 | - |
| 343 | TLSA | Tiziana Life Sciences Ltd | 143.53M | 0.91% | 279,332 | - |
| 344 | MOLN | Molecular Partners AG | 143.28M | -6.33% | 5,741 | 856.30K |
| 345 | OTLK | Outlook Therapeutics, Inc. | 140.20M | -4.92% | 23,474,994 | 333.14K |
| 346 | SPRB | Spruce Biosciences, Inc. | 137.35M | -3.83% | 69,010 | 697.00K |
| 347 | AGEN | Agenus Inc. | 135.34M | -1.52% | 455,024 | 123.87M |
| 348 | GUTS | Fractyl Health, Inc. | 134.85M | - | 1,736,196 | 3.00K |
| 349 | GNLX | Genelux Corporation | 134.11M | 2.03% | 140,153 | 8.00K |
| 350 | ADCT | ADC Therapeutics SA | 133.55M | - | 1,851,125 | 79.18M |
| 351 | ACOG | Alpha Cognition Inc. | 130.43M | - | 24,991 | 10.83M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 129.71M | -2.83% | 330,513 | 233.00K |
| 353 | ALPS | Alps Group Inc | 128.11M | 6.22% | 6,910 | 3.74M |
| 354 | MENS | Jyong Biotech Ltd. | 118.77M | 1.27% | 269,339 | - |
| 355 | ENGN | enGene Therapeutics Inc. | 118.57M | 9.26% | 2,157,978 | - |
| 356 | COYA | Coya Therapeutics, Inc. | 114.71M | 3.16% | 186,729 | 7.94M |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 114.18M | -5.05% | 89,591 | 39.99K |
| 358 | PLYX | Polaryx Therapeutics, Inc. | 110.78M | -1.27% | 158,146 | - |
| 359 | PYXS | Pyxis Oncology, Inc. | 110.24M | -1.14% | 650,115 | 13.86M |
| 360 | CGTX | Cognition Therapeutics, Inc. | 108.12M | - | 858,106 | - |
| 361 | ALDX | Aldeyra Therapeutics, Inc. | 106.17M | - | 627,229 | - |
| 362 | PEPG | PepGen Inc. | 105.83M | 4.08% | 454,102 | - |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 101.59M | -1.39% | 83,947 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 101.47M | 5.88% | 1,193,089 | - |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 99.81M | 1.40% | 31,118 | 37.16M |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 98.56M | -1.71% | 2,206,179 | 70.00M |
| 367 | VANI | Vivani Medical, Inc. | 97.45M | 2.73% | 229,890 | - |
| 368 | CRDF | Cardiff Oncology, Inc. | 97.09M | -7.79% | 1,286,226 | 525.00K |
| 369 | CBUS | Cibus, Inc. | 96.94M | 3.25% | 342,273 | 3.64M |
| 370 | FBIO | Fortress Biotech, Inc. | 95.01M | 3.25% | 463,992 | 66.16M |
| 371 | SEER | Seer, Inc. | 94.02M | -0.58% | 106,695 | 15.17M |
| 372 | PTHS | Pelthos Therapeutics Inc. | 92.10M | -3.64% | 64,743 | 27.70M |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | - | 911,870 | 65.34K |
| 374 | PMN | ProMIS Neurosciences, Inc. | 90.13M | -2.90% | 6,928 | - |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 89.74M | -4.32% | 80,671 | 23.14M |
| 376 | PYPD | PolyPid Ltd. | 89.45M | 0.97% | 34,096 | - |
| 377 | CSBR | Champions Oncology, Inc. | 88.04M | -2.46% | 8,802 | 57.95M |
| 378 | RNTX | Rein Therapeutics Inc. | 87.69M | -1.61% | 594,881 | - |
| 379 | BMEA | Biomea Fusion, Inc. | 86.76M | 2.56% | 811,581 | - |
| 380 | ICCC | ImmuCell Corporation | 86.22M | -1.55% | 9,741 | 29.93M |
| 381 | ACET | Adicet Bio, Inc. | 85.16M | 0.75% | 32,009 | - |
| 382 | ANIX | Anixa Biosciences, Inc. | 84.38M | 0.40% | 172,309 | - |
| 383 | NRXS | NeurAxis, Inc. | 84.21M | 1.49% | 81,506 | 4.28M |
| 384 | RLYB | Rallybio Corporation | 84.11M | -0.13% | 138,591 | 858.00K |
| 385 | CUE | Cue Biopharma, Inc. | 83.99M | 5.18% | 79,089 | 32.73M |
| 386 | AARD | Aardvark Therapeutics, Inc. | 83.77M | -1.54% | 206,542 | - |
| 387 | MAIA | MAIA Biotechnology, Inc. | 82.69M | 4.62% | 1,133,105 | - |
| 388 | ATHE | Alterity Therapeutics Limited | 81.65M | 4.75% | 7,635 | 4.43M |
| 389 | OKYO | OKYO Pharma Limited | 79.77M | - | 79,789 | - |
| 390 | LONA | LeonaBio, Inc. | 79.38M | 1.20% | 7,718 | - |
| 391 | LIXT | Lixte Biotechnology Holdings, Inc. | 78.07M | 8.56% | 348,836 | - |
| 392 | HYFT | MindWalk Holdings Corp. | 77.48M | - | 241,729 | 20.70M |
| 393 | RANI | Rani Therapeutics Holdings, Inc. | 76.67M | 1.05% | 796,189 | 3.17M |
| 394 | OSTX | OS Therapies Incorporated | 76.61M | 1.18% | 169,492 | - |
| 395 | HRTX | Heron Therapeutics, Inc. | 76.49M | 1.00% | 3,952,886 | 150.71M |
| 396 | ANVS | Annovis Bio, Inc. | 75.72M | - | 740,839 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 75.06M | -72.53% | 8,464,282 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 74.64M | 4.17% | 447,151 | - |
| 399 | XBIT | XBiotech Inc. | 71.65M | 0.43% | 17,051 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 70.59M | 0.88% | 375,197 | - |
| 401 | BYSI | BeyondSpring Inc. | 67.85M | 5.10% | 13,663 | 1.88M |
| 402 | CING | Cingulate Inc. | 65.45M | 1.02% | 247,131 | - |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 65.06M | 2.70% | 394,861 | - |
| 404 | IMA | ImageneBio, Inc. | 62.49M | -1.42% | 22,010 | 800.00K |
| 405 | INKT | MiNK Therapeutics, Inc. | 62.45M | 4.28% | 27,557 | - |
| 406 | CNTX | Context Therapeutics Inc. | 62.40M | -51.14% | 20,588,819 | - |
| 407 | EXOZ | eXoZymes, Inc. | 62.32M | 3.52% | 1,644 | -700.00 |
| 408 | TCRX | TScan Therapeutics, Inc. | 62.11M | 4.20% | 646,463 | 9.14M |
| 409 | MNOV | MediciNova, Inc. | 61.53M | 1.63% | 122,088 | 596.64K |
| 410 | IBIO | iBio, Inc. | 59.64M | -2.37% | 754,000 | 300.00K |
| 411 | ENTX | Entera Bio Ltd. | 59.56M | -1.63% | 86,591 | 42.00K |
| 412 | IBO | Impact BioMedical Inc. | 59.52M | -5.64% | 69,243 | 39.00K |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 59.33M | 8.73% | 37,720 | - |
| 414 | FLNA | Filana Therapeutics, Inc. | 58.45M | -3.20% | 473,312 | - |
| 415 | PDSB | PDS Biotechnology Corporation | 56.93M | -2.86% | 1,150,328 | - |
| 416 | PMVP | PMV Pharmaceuticals, Inc. | 56.53M | -4.50% | 197,898 | - |
| 417 | MCRB | Seres Therapeutics, Inc. | 54.42M | -1.40% | 152,605 | 1.15M |
| 418 | TIL | Instil Bio, Inc. | 53.71M | - | 29,053 | - |
| 419 | EDSA | Edesa Biotech, Inc. | 52.78M | 2.41% | 185,979 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 52.44M | 1.95% | 70,702 | - |
| 421 | VERU | Veru Inc. | 50.24M | 4.33% | 497,567 | 16.89M |
| 422 | XLO | Xilio Therapeutics, Inc. | 49.90M | 0.36% | 67,531 | 53.48M |
| 423 | KALA | KALA BIO, Inc. | 49.08M | 0.38% | 90,311 | - |
| 424 | ACTU | Actuate Therapeutics, Inc. | 49.05M | 1.49% | 120,857 | - |
| 425 | IMMP | Immutep Limited | 48.02M | 1.81% | 230,515 | 5.28M |
| 426 | RADX | Radiopharm Theranostics Limited | 47.70M | 4.22% | 27,452 | 10.86M |
| 427 | MREO | Mereo BioPharma Group plc | 47.25M | -2.95% | 1,538,813 | 500.00K |
| 428 | LTRN | Lantern Pharma Inc. | 47.08M | -4.90% | 197,652 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | 2.38% | 124,630 | - |
| 430 | ESLA | Estrella Immunopharma, Inc. | 44.33M | -2.83% | 40,352 | - |
| 431 | MGX | Metagenomi Therapeutics, Inc. | 44.05M | -2.50% | 332,152 | 22.33M |
| 432 | ATYR | aTyr Pharma, Inc. | 43.47M | 0.66% | 1,620,888 | 190.00K |
| 433 | GNTA | Genenta Science S.p.A. | 42.46M | -3.74% | 249,550 | - |
| 434 | TVGN | Tevogen Bio Holdings Inc. | 41.96M | -4.30% | 16,778 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 41.48M | 7.35% | 487,042 | 1.04M |
| 436 | NTRB | Nutriband Inc. | 41.45M | 0.59% | 4,363 | 1.80M |
| 437 | RNXT | RenovoRx, Inc. | 39.95M | 4.98% | 173,847 | 1.49M |
| 438 | GOSS | Gossamer Bio, Inc. | 39.19M | 3.15% | 16,232,315 | 55.54M |
| 439 | GRCE | Grace Therapeutics, Inc. | 34.20M | 0.45% | 365,843 | - |
| 440 | INMB | INmune Bio Inc. | 34.03M | 3.23% | 220,303 | 50.00K |
| 441 | PSTV | Plus Therapeutics, Inc. | 33.38M | -3.19% | 297,037 | 5.18M |
| 442 | GRDX | GridAI Technologies Corp. | 32.33M | -7.78% | 208,045 | - |
| 443 | NNVC | NanoViricides, Inc. | 32.12M | 15.57% | 635,342 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 31.84M | 5.88% | 92,312 | 797.92K |
| 445 | ALGS | Aligos Therapeutics, Inc. | 31.62M | -3.22% | 87,565 | 4.71M |
| 446 | LSTA | Lisata Therapeutics, Inc. | 31.42M | -3.09% | 32,191 | 170.00K |
| 447 | BOLD | Boundless Bio, Inc. | 31.38M | -0.71% | 23,013 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 31.37M | -0.99% | 101,560 | 90.00K |
| 449 | APLM | Apollomics, Inc. | 30.42M | -3.21% | 1,144 | 8.84M |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 30.12M | 0.73% | 240,172 | 38.00K |
| 451 | EVAX | Evaxion A/S | 30.02M | -1.10% | 28,883 | 7.53M |
| 452 | DARE | Daré Bioscience, Inc. | 29.66M | -1.98% | 221,852 | 1.16M |
| 453 | DYAI | Dyadic International, Inc. | 29.00M | 16.70% | 263,545 | 3.81M |
| 454 | BRNS | Barinthus Biotherapeutics plc | 28.61M | 4.38% | 197,211 | 14.97M |
| 455 | SER | Serina Therapeutics, Inc. | 28.46M | 3.80% | 106,878 | 130.00K |
| 456 | KYNB | Kyntra Bio, Inc. | 27.81M | -3.65% | 10,117 | 7.44M |
| 457 | IGC | IGC Pharma, Inc. | 27.70M | 0.14% | 682,602 | 1.11M |
| 458 | LITS | Lite Strategy, Inc. | 27.24M | 8.02% | 241,610 | - |
| 459 | SKYE | Skye Bioscience, Inc. | 25.63M | -7.33% | 186,276 | - |
| 460 | PLUR | Pluri Inc. | 25.14M | 2.64% | 5,531 | 1.08M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 25.05M | 1.14% | 73,036 | - |
| 462 | LGVN | Longeveron Inc. | 24.61M | 0.95% | 162,775 | 1.22M |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 24.29M | -6.56% | 298,754 | - |
| 464 | BCTX | BriaCell Therapeutics Corp. | 24.27M | -1.08% | 135,413 | - |
| 465 | QNTM | Quantum BioPharma Ltd. | 23.48M | -3.39% | 171,677 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 23.19M | -1.83% | 106,973 | -13.27K |
| 467 | CRVO | CervoMed Inc. | 22.96M | 1.22% | 9,533,374 | 2.09M |
| 468 | ALLR | Allarity Therapeutics, Inc. | 22.88M | 3.50% | 65,838 | 345.00K |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 22.70M | -0.56% | 1,045,425 | 789.00K |
| 470 | PTN | Palatin Technologies, Inc. | 22.61M | -8.16% | 21,850 | 12.88M |
| 471 | MRKR | Marker Therapeutics, Inc. | 22.51M | -2.17% | 51,305 | 3.55M |
| 472 | CELU | Celularity Inc. | 22.29M | 8.01% | 675,285 | 26.55M |
| 473 | VYNE | VYNE Therapeutics Inc. | 20.73M | -4.09% | 552,440 | 454.00K |
| 474 | PLRZ | Polyrizon Ltd. | 20.27M | -2.70% | 25,090 | - |
| 475 | ATOS | Atossa Therapeutics, Inc. | 20.24M | -4.47% | 477,652 | - |
| 476 | HOWL | Werewolf Therapeutics, Inc. | 18.90M | 2.07% | 346,289 | 1.14M |
| 477 | LPCN | Lipocine Inc. | 18.88M | 1.33% | 71,188 | 2.00M |
| 478 | KTTA | Pasithea Therapeutics Corp. | 18.71M | -5.26% | 495,229 | - |
| 479 | CLRB | Cellectar Biosciences, Inc. | 18.70M | 4.93% | 167,570 | - |
| 480 | SNSE | Sensei Biotherapeutics, Inc. | 18.59M | 6.54% | 219,749 | - |
| 481 | TPST | Tempest Therapeutics, Inc. | 17.93M | -0.79% | 70,743 | - |
| 482 | XCUR | Exicure, Inc. | 17.78M | 0.36% | 35,560 | 500.00K |
| 483 | PASG | Passage Bio, Inc. | 17.64M | -5.34% | 40,139 | - |
| 484 | AEON | AEON Biopharma, Inc. | 17.49M | -7.01% | 48,212 | - |
| 485 | NCEL | NewcelX Ltd. | 17.23M | -0.93% | 7,728 | - |
| 486 | GTBP | GT Biopharma, Inc. | 16.90M | 4.85% | 2,337,601 | - |
| 487 | CRIS | Curis, Inc. | 16.62M | -1.26% | 168,054 | 7.06M |
| 488 | MLEC | Moolec Science SA | 15.87M | -0.26% | 8,482 | 7.83M |
| 489 | HIND | Vyome Holdings, Inc. | 15.23M | -5.65% | 15,531 | 152.72K |
| 490 | QNCX | Quince Therapeutics, Inc. | 15.18M | -0.29% | 215,572 | - |
| 491 | AKTX | Akari Therapeutics, Plc | 15.07M | -1.72% | 61,953 | - |
| 492 | LEXX | Lexaria Bioscience Corp. | 15.02M | -1.38% | 34,399 | 368.00K |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 14.82M | - | 290,480 | 5.61M |
| 494 | CVM | CEL-SCI Corporation | 14.64M | -6.48% | 682,257 | - |
| 495 | MBRX | Moleculin Biotech, Inc. | 14.46M | 2.65% | 119,258 | - |
| 496 | CALC | CalciMedica, Inc. | 13.70M | 0.35% | 52,510 | - |
| 497 | INAB | IN8bio, Inc. | 13.69M | -2.80% | 30,686 | - |
| 498 | COCP | Cocrystal Pharma, Inc. | 13.65M | -0.48% | 131,995 | 225.00K |
| 499 | GDTC | CytoMed Therapeutics Limited | 13.61M | 0.88% | 4,198 | 669.28K |
| 500 | BLRX | BioLineRx Ltd. | 13.56M | -3.71% | 20,041 | 1.40M |